COVID-19 Associated Pneumonia and Pleural Effusion Masquerading as Heart Failure in Rheumatic Heart Disease

Jahanzeb Malik1, Nismat Javed2, Hesham Naeem1

  • 1Rawalpindi Institute of Cardiology, Rawal Road, Rawalpindi, Pakistan.

Insights

This study highlights unusual radiological findings in a COVID-19 patient with rheumatic heart disease in Pakistan. Early aggressive treatment is crucial for managing COVID-19 pneumonia, even with rare presentations like pleural effusion.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Radiology

Background:

  • The COVID-19 pandemic, caused by the SARS-CoV-2 virus, emerged in Pakistan in April 2020.
  • The country anticipated its peak in August 2020, necessitating urgent public health responses.
  • Rheumatic heart disease (RHD) is a significant cardiovascular condition, particularly in low-resource settings.

Purpose of the Study:

  • To report a unique case of COVID-19 in a patient with pre-existing rheumatic heart disease.
  • To describe unusual radiological findings associated with SARS-CoV-2 infection.
  • To emphasize the importance of early and aggressive treatment for COVID-19 pneumonia.

Main Methods:

  • Case report detailing clinical presentation, symptoms (fever, myalgia), and diagnostic workup.
  • Review of radiological findings, specifically focusing on an unusual presentation.
  • Analysis of treatment response to aggressive therapeutic interventions.

Main Results:

  • The patient presented with symptoms including fever and myalgia, alongside a diagnosis of rheumatic heart disease.
  • An unusual radiological finding, specifically pleural effusion, was observed in a mildly symptomatic COVID-19 patient.
  • Aggressive treatment led to a dramatic improvement in COVID-19 pneumonia.

Conclusions:

  • Unusual radiological findings are increasingly recognized in COVID-19 patients.
  • Pleural effusion represents a rare manifestation of COVID-19, even in mildly symptomatic individuals.
  • Prompt and intensive treatment strategies are vital for successful management of COVID-19 pneumonia.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
279
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
295
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
166
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
170
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
341
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
312